코데인에 의해 유발된 두드러기 및 혈관부종 1예
A Case of Codeine Induced Urticaria/Angioedema
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
A 26-year-old female patient had complained of generalized urticaria with perioral and periorbital angioedema within 30 minutes after taking 20 mg of codeine phosphate. She had suffered from allergic rhinitis sensitized to animal danders, tree and weed pollens. Skin prick test (SPT) and basophil histamine release test with codeine phosphate (0.1, 1 and 10 mg/mL) were done with cytochrome P4502D6 (CYP2D6) genotyping. The skin prick test showed that the wheal/ erythema size of codeine phosphate (10 mg/mL) and morphine (10 mg/mL) were 3×2/14×7 and 3×2/15×8 mm, when compared to that of histamine (4×3/22×19 mm). The results of CYP2D6 genotype revealed that she has CYP2D6*10B/ *10B allele which means decreased turnover to morphine. Histamine releasing ability in response to codeine phosphate were ennanced in a dose-dependent manner (11.47% in 0.1 mg/mL, 62.84% in 1 mg/mL and 91.74% in 10 mg/ mL, respectively), while minimal histamine release was shown in control basophils. To the best of our knowledge, this is the first case of codeine-induced urticaria/angioedema, which has been caused by direct histamine releasing effect of codeine itself in Korea. (Korean J Asthma Allergy Clin Immunol 2008;28:234-237)
Abstract
A 26-year-old female patient had complained of generalized urticaria with perioral and periorbital angioedema within 30 minutes after taking 20 mg of codeine phosphate. She had suffered from allergic rhinitis sensitized to animal danders, tree and weed pollens. Skin prick test (SPT) and basophil histamine release test with codeine phosphate (0.1, 1 and 10 mg/mL) were done with cytochrome P4502D6 (CYP2D6) genotyping. The skin prick test showed that the wheal/ erythema size of codeine phosphate (10 mg/mL) and morphine (10 mg/mL) were 3×2/14×7 and 3×2/15×8 mm, when compared to that of histamine (4×3/22×19 mm). The results of CYP2D6 genotype revealed that she has CYP2D6*10B/ *10B allele which means decreased turnover to morphine. Histamine releasing ability in response to codeine phosphate were ennanced in a dose-dependent manner (11.47% in 0.1 mg/mL, 62.84% in 1 mg/mL and 91.74% in 10 mg/ mL, respectively), while minimal histamine release was shown in control basophils. To the best of our knowledge, this is the first case of codeine-induced urticaria/angioedema, which has been caused by direct histamine releasing effect of codeine itself in Korea. (Korean J Asthma Allergy Clin Immunol 2008;28:234-237)
참고문헌 (18)
- Vree TB, "Pharmacokinetics and metabolism of codeine in humans", Biopharm Drug Dispos, 13, pp.445~460 (1992)
- Quiding H, "Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery", Eur J Clin Pharmacol, 44, pp.319~323 (1993)
- Casale TB, "Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation", J Allergy Clin Immunol, 73, pp.775~781 (1984)
- Arndt KA, "Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program", JAMA, 235, pp.918~923 (1976)
- Schoenfeld MR, "Acute allergic reactions to morphine, codeine, meperidine, hydrocholoride, and opium alkaloid", N Y State J Med, 60, pp.2591~2593 (1960)
- De Groot AC, "Allergic urticarial rash from oral codeine", Contact Dermatitis, 14, pp.209~214 (1986)
- Rodríguez A, "Generalized dermatitis due to codeine. Cross-sensitization among opium alkaloids", Contact Dermatitis, 53, pp.240~ (2005)
- Vidal C, "Fever and urticaria to codeine", Allergy, 55, pp.416~417 (2000)
- Harle DG, "Anaphylaxis following administration of papaveretum. Case report: implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant", Anesthesiology, 71, pp.489~494 (1989)
- Kuokkanen K, "Erythema fixum of the genitals and the mucous membranes", Int J Dermatol, 13, pp.4~8 (1974)
- Tӧrӧk H, "Dermatitis medicamentosa: a ten-year study", Dermatol Int, 8, pp.57~62 (1969)
- Ponte CD, "A suspected case of codeine-induced erythema multiforme", Drug Intell Clin Pharm, 17, pp.128~130 (1983)
- Hunskaar S, "Scarlatiniform rash and urticaria due to codeine", Ann Allergy, 54, pp.240~241 (1985)
- Rodriguez F, "Generalized dermatitis due to codeine", Contact Dermatitis, 32, pp.120~ (1995)
- Nasser SM, "Opiate-sensitivity: clinical characteristics and the role of skin prick testing", Clin Exp Allergy, 31, pp.1014~1020 (2001)
- Kubota T, "Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes", Br J Clin Pharmacol, 50, pp.31~34 (2000)
- Droll K, "Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians", Pharmacogenetics, 8, pp.325~333 (1998)
- Yu A, "Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms", J Pharmacol Exp Ther, 303, pp.1291~1300 (2002)